Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects With Incomplete Response to Lamivudine

ClinicalTrials.gov ID: NCT00036608

Public ClinicalTrials.gov record NCT00036608. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 8:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this clinical research study is to assess the safety and effectiveness of switching to entecavir compared to continued lamivudine in patients with chronic hepatitis B.

Study identification

NCT ID
NCT00036608
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
16 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2002 (Type not available)
Primary completion
Feb 2005 (Actual)
Completion
Feb 2005 (Actual)
Last update posted
Apr 14, 2011

2002 – 2005

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Local Investigator Birmingham Alabama 35294 —
Local Investigator Tucson Arizona 85724 —
Local Investigator La Jolla California 92037 —
Local Investigator Los Angeles California 90048 —
Local Investigator Los Angeles California 90095 —
Local Investigator Orange California 92868 —
Local Investigator San Diego California 92115 —
Local Investigator San Francisco California 94115 —
Local Investigator Farmington Connecticut 06030 —
Local Investigator Miami Florida 33136 —
Local Investigator Miami Beach Florida 33140 —
Local Investigator Atlanta Georgia 30309 —
Local Investigator Atlanta Georgia 30322 —
Local Investigator Honolulu Hawaii 96820 —
Local Investigator Chicago Illinois 60612 —
Local Investigator Chicago Illinois 60622 —
Local Investigator Iowa City Iowa 52242 —
Local Investigator New Orleans Louisiana 70112 —
Local Investigator Dundalk Maryland 21205 —
Local Investigator Boston Massachusetts 02111 —
Local Investigator Worcester Massachusetts 01655 —
Local Investigator Ann Arbor Michigan 48109 —
Local Investigator Royal Oak Michigan 48073 —
Local Investigator Saint Paul Minnesota 55114 —
Local Investigator Manhasset New York 11030 —
Local Investigator New York New York 10003 —
Local Investigator New York New York 10029 —
Local Investigator New York New York 10032 —
Local Investigator Rochester New York 14642 —
Local Investigator Charlotte North Carolina 28203 —
Local Investigator Durham North Carolina 27710 —
Local Investigator Cleveland Ohio 44125 —
Local Investigator Philadelphia Pennsylvania 19104 —
Local Investigator Pittsburgh Pennsylvania 15213 —
Local Investigator Providence Rhode Island 02908 —
Local Investigator Nashville Tennessee 37211 —
Local investigator Dallas Texas 75235 —
Local Investigator Fairfax Virginia 22031 —
Local Investigator Richmond Virginia 23249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00036608, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 14, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00036608 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →